Philippe Leissner

2.1k total citations
29 papers, 1.4k citations indexed

About

Philippe Leissner is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Philippe Leissner has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Philippe Leissner's work include Virus-based gene therapy research (10 papers), HIV Research and Treatment (4 papers) and Molecular Biology Techniques and Applications (4 papers). Philippe Leissner is often cited by papers focused on Virus-based gene therapy research (10 papers), HIV Research and Treatment (4 papers) and Molecular Biology Techniques and Applications (4 papers). Philippe Leissner collaborates with scholars based in France, United Kingdom and United States. Philippe Leissner's co-authors include Majid Mehtali, Alain Puisieux, Alexander Krause, Sandrine Valsesia‐Wittmann, Didier Négre, Philippe Mangeot, Valérie Combaret, François–Loïc Cosset, Thibault Verjat and Bruno Mougin and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Philippe Leissner

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Leissner France 18 678 316 295 290 281 29 1.4k
Christopher S. Barker United States 13 550 0.8× 557 1.8× 186 0.6× 128 0.4× 181 0.6× 25 1.2k
Shari M. Kaiser United States 11 553 0.8× 208 0.7× 153 0.5× 289 1.0× 283 1.0× 26 1.1k
Heather L. Howie United States 20 693 1.0× 614 1.9× 207 0.7× 393 1.4× 288 1.0× 37 1.7k
M Kuppuswamy United States 18 766 1.1× 138 0.4× 525 1.8× 232 0.8× 149 0.5× 27 1.5k
Claudia Stewart United States 17 469 0.7× 231 0.7× 276 0.9× 305 1.1× 457 1.6× 28 1.3k
Mel Campbell United States 26 945 1.4× 541 1.7× 220 0.7× 526 1.8× 315 1.1× 42 1.8k
Alessandra Handisurya Austria 23 401 0.6× 474 1.5× 156 0.5× 356 1.2× 283 1.0× 54 1.6k
Ralph F. Hopkins United States 16 570 0.8× 397 1.3× 191 0.6× 493 1.7× 660 2.3× 22 1.8k
Koon-Chu Yaiw Sweden 18 201 0.3× 570 1.8× 152 0.5× 183 0.6× 233 0.8× 31 997
Tapani Ronni Finland 21 692 1.0× 344 1.1× 99 0.3× 412 1.4× 1.1k 3.9× 24 2.0k

Countries citing papers authored by Philippe Leissner

Since Specialization
Citations

This map shows the geographic impact of Philippe Leissner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Leissner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Leissner more than expected).

Fields of papers citing papers by Philippe Leissner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Leissner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Leissner. The network helps show where Philippe Leissner may publish in the future.

Co-authorship network of co-authors of Philippe Leissner

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Leissner. A scholar is included among the top collaborators of Philippe Leissner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Leissner. Philippe Leissner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leissner, Philippe, et al.. (2023). Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study. BMC Endocrine Disorders. 23(1). 179–179. 12 indexed citations
2.
Perret, Magali, Erwin Sentausa, Philippe Leissner, et al.. (2023). Comparison of DNA extraction methods for 16S rRNA gene sequencing in the analysis of the human gut microbiome. Scientific Reports. 13(1). 10279–10279. 22 indexed citations
3.
Tabone, Olivier, Raman Verma, Akul Singhania, et al.. (2021). Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis. The Journal of Experimental Medicine. 218(10). 47 indexed citations
4.
Venet, Fabienne, Anne‐Claire Lukaszewicz, Karen Brengel‐Pesce, et al.. (2021). Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries—Insights from the REALISM Study. Journal of Clinical Medicine. 11(1). 96–96. 14 indexed citations
5.
Mallet, François, Magali Perret, Frédéric Reynier, et al.. (2021). Herpes DNAemia and TTV Viraemia in Intensive Care Unit Critically Ill Patients: A Single-Centre Prospective Longitudinal Study. Frontiers in Immunology. 12. 698808–698808. 24 indexed citations
6.
Mallet, François, Magali Perret, Olivier Tabone, et al.. (2019). Early herpes and TTV DNAemia in septic shock patients: a pilot study. Intensive Care Medicine Experimental. 7(1). 28–28. 16 indexed citations
7.
Singhania, Akul, Raman Verma, Christine M. Graham, et al.. (2018). A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection. Nature Communications. 9(1). 2308–2308. 133 indexed citations
8.
Jang, Eun Sun, Sook‐Hyang Jeong, Jin‐Wook Kim, et al.. (2016). Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma. PLoS ONE. 11(3). e0151069–e0151069. 79 indexed citations
9.
Jang, Eun Sun, Yun Suk Choi, Philippe Leissner, et al.. (2014). Performance of Biomarkers for Diagnosis of Hepatocellular Carcinoma–alpha Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin and Dickkopf-1. 71–72. 2 indexed citations
10.
Lamy, Pierre‐Jean, et al.. (2007). Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Type-1 mRNA Assessment in Breast Cancer by Means of NASBA. American Journal of Clinical Pathology. 128(3). 404–413. 11 indexed citations
11.
Leissner, Philippe, Thibault Verjat, Thomas Bachelot, et al.. (2006). Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer. BMC Cancer. 6(1). 216–216. 21 indexed citations
12.
Lamy, Pierre‐Jean, et al.. (2005). NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 44(1). 3–12. 10 indexed citations
13.
Pachot, Alexandre, Guillaume Monneret, Nicolas Voirin, et al.. (2004). Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clinical Immunology. 114(1). 61–69. 77 indexed citations
14.
Krause, Alexander, Valérie Combaret, Isabelle Iacono, et al.. (2004). Genome-wide analysis of gene expression in neuroblastomas detected by mass screening. Cancer Letters. 225(1). 111–120. 38 indexed citations
15.
Legrand, Valérie, et al.. (2002). Transductional Targeting with Recombinant Adenovirus Vectors. Current Gene Therapy. 2(3). 323–339. 20 indexed citations
16.
Leissner, Philippe, Valérie Legrand, Y. Schlesinger, et al.. (2001). Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Therapy. 8(1). 49–57. 78 indexed citations
17.
Sanhadji, Kamel, Linda Grave, Jean‐Louis Touraine, et al.. (2000). Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice. AIDS. 14(18). 2813–2822. 18 indexed citations
18.
Négre, Didier, Philippe Mangeot, Ghislaine Duisit, et al.. (2000). Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Therapy. 7(19). 1613–1623. 172 indexed citations
19.
Leissner, Philippe, V. Calenda, Kamel Sanhadji, et al.. (1998). In vitro and in vivo inhibition of HIV-1 replication by retroviral transfer of TAT-inducible interferon alpha, bêta or gamma genes: application to gene therapy for Aids. Annales de biologie clinique. 56(2). 2 indexed citations
20.
Sanhadji, Kamel, Philippe Leissner, F. Pelloquin, et al.. (1997). Experimental gene therapy. AIDS. 11(8). 977–986. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026